Novartis AG

Historical 13F Holders

Symbol
NVS
CUSIP
66987V109
All holders as of
Q3 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 1,423 134 M $17.2 B
2025 Q2 1,415 134 M $16.2 B
2025 Q1 1,389 139 M $15.4 B
2024 Q4 1,372 131 M $12.7 B
2024 Q3 1,351 133 M $15.2 B
2024 Q2 1,356 146 M $15.5 B
2024 Q1 1,289 155 M $15.0 B
2023 Q4 1,312 152 M $15.3 B
2023 Q3 1,258 149 M $15.1 B
2023 Q2 1,242 149 M $15.0 B
2023 Q1 1,219 176 M $15.3 B
2022 Q4 1,228 173 M $16.1 B
2022 Q3 1,125 184 M $14.0 B
2022 Q2 1,168 200 M $16.9 B
2022 Q1 1,171 209 M $18.3 B
2021 Q4 1,181 211 M $18.5 B
2021 Q3 1,116 220 M $18.0 B
2021 Q2 1,151 217 M $19.8 B
2021 Q1 1,172 219 M $18.7 B
2020 Q4 1,226 231 M $22.2 B
2020 Q3 1,172 226 M $19.7 B
2020 Q2 1,176 238 M $20.8 B
2020 Q1 1,186 249 M $20.5 B
2019 Q4 1,220 260 M $24.6 B
2019 Q3 1,133 244 M $21.3 B
2019 Q2 1,155 259 M $23.7 B
2019 Q1 1,180 274 M $26.2 B
2018 Q4 1,124 273 M $23.4 B
2018 Q3 1,069 261 M $22.5 B
2018 Q2 1,018 257 M $19.4 B
2018 Q1 1,047 256 M $20.7 B
2017 Q4 1,040 251 M $21.1 B
2017 Q3 972 259 M $22.2 B
2017 Q2 956 260 M $21.7 B
2017 Q1 942 272 M $20.2 B
2016 Q4 938 255 M $18.6 B
2016 Q3 911 239 M $18.9 B
2016 Q2 913 237 M $19.6 B
2016 Q1 905 239 M $17.3 B
2015 Q4 963 236 M $20.4 B
2015 Q3 954 234 M $21.5 B
2015 Q2 973 236 M $23.2 B
2015 Q1 967 234 M $23.6 B
2014 Q4 958 236 M $22.4 B
2014 Q3 915 234 M $22.6 B
2014 Q2 878 239 M $22.2 B
2014 Q1 867 238 M $20.8 B